What is Regeneron Pharmaceuticals's long- term investments?

Regeneron Pharmaceuticals (REGN) reported long- term investments of $9.79B in Q1 2026.

How has Regeneron Pharmaceuticals's long- term investments changed year-over-year?

Regeneron Pharmaceuticals's long- term investments increased by 5.5% year-over-year, from $9.28B to $9.79B.

What is the long-term trend for Regeneron Pharmaceuticals's long- term investments?

Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's long- term investments has grown at a 26.8% compound annual growth rate (CAGR), from $3.14B to $10.26B.

Regeneron Pharmaceuticals REGN Long- term Investments

Long- term Investments at other companies

Merck & Co.MRK

——

Gilead SciencesGILD

——

Vertex PharmaceuticalsVRTX

——

Other financials

Income statement

See full

Revenue$3.6B+19.0%

Operating income$642.9M+8.6%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.1%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$63.95B+17.8%

Enterprise value$63.68B+18.1%

P/E14.5×+2.4×

P/S4.3×+0.4×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's long- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's long- term investments?: Regeneron Pharmaceuticals (REGN) reported long- term investments of $9.79B in Q1 2026.
How has Regeneron Pharmaceuticals's long- term investments changed year-over-year?: Regeneron Pharmaceuticals's long- term investments increased by 5.5% year-over-year, from $9.28B to $9.79B.
What is the long-term trend for Regeneron Pharmaceuticals's long- term investments?: Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's long- term investments has grown at a 26.8% compound annual growth rate (CAGR), from $3.14B to $10.26B.